Heart failure and mouse models

被引:75
作者
Breckenridge, Ross [1 ]
机构
[1] Natl Inst Med Res, MRC, London NW7 1AA, England
关键词
MYOSIN HEAVY-CHAIN; CARDIAC-HYPERTROPHY; CARDIOVASCULAR-DISEASE; GENE-EXPRESSION; STRESSED HEART; FAILING HEART; END-POINTS; MICE; CARDIOMYOPATHY; EPIDEMIOLOGY;
D O I
10.1242/dmm.005017
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Heart failure is a common, complex condition with a poor prognosis and increasing incidence. The syndrome of heart failure comprises changes in electrophysiology, contraction and energy metabolism. This complexity, and the interaction of the clinical syndrome with very frequently concurrent medical conditions such as diabetes, means that animal modelling of heart failure is difficult. The current animal models of heart failure in common use do not address several important clinical problems. There have been major recent advances in the understanding of cardiac biology in the healthy and failing myocardium, but these are, as yet, unmatched by advances in therapeutics. Arguably, the development of new animal models of heart failure, or at least adaptation of existing models, will be necessary to fully translate scientific advances in this area into new drugs. This review outlines the mouse models of heart failure in common usage today, and discusses how adaptations in these models may allow easier translation of animal experimentation into the clinical arena.
引用
收藏
页码:138 / 143
页数:6
相关论文
共 53 条
[31]   Heterozygous disruption of SERCA2a is not associated with impairment of cardiac performance in humans: implications for SERCA2a as a therapeutic target in heart failure [J].
Mayosi, BM ;
Kardos, A ;
Davies, CH ;
Gumedze, F ;
Hovnanian, A ;
Burge, S ;
Watkins, H .
HEART, 2006, 92 (01) :105-109
[32]   Epidemiology, aetiology, and prognosis of heart failure [J].
McMurray, JJ ;
Stewart, S .
HEART, 2000, 83 (05) :596-602
[33]   A calcineurin-dependent transcriptional pathway for cardiac hypertrophy [J].
Molkentin, JD ;
Lu, JR ;
Antos, CL ;
Markham, B ;
Richardson, J ;
Robbins, J ;
Grant, SR ;
Olson, EN .
CELL, 1998, 93 (02) :215-228
[34]   Multipotent Islet-1 Cardiovascular Progenitors in Development and Disease [J].
Nakano, A. ;
Nakano, H. ;
Chien, K. R. .
CONTROL AND REGULATION OF STEM CELLS, 2008, 73 :297-+
[35]   Sizing up the heart: development redux in disease [J].
Olson, EN ;
Schneider, MD .
GENES & DEVELOPMENT, 2003, 17 (16) :1937-1956
[36]   Phosphoinositide 3-kinase γ-deficient mice are protected from isoproterenol-induced heart failure [J].
Oudit, GY ;
Crackower, MA ;
Eriksson, U ;
Sarao, R ;
Kozieradzki, I ;
Sasaki, T ;
Irie-Sasaki, J ;
Gidrewicz, D ;
Rybin, VO ;
Wada, T ;
Steinberg, SF ;
Backx, PH ;
Penninger, JM .
CIRCULATION, 2003, 108 (17) :2147-2152
[37]   Epidemiology of diastolic heart failure [J].
Owan, TE ;
Redfield, MM .
PROGRESS IN CARDIOVASCULAR DISEASES, 2005, 47 (05) :320-332
[38]   Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction [J].
Perrino, Cinzia ;
Prasad, Sathyamangla V. Naga ;
Mao, Lan ;
Noma, Takahisa ;
Yan, Zhen ;
Kim, Hyung-Suk ;
Smithies, Oliver ;
Rockman, Howard A. .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (06) :1547-1560
[39]   Transcription factors and heart failure: Does the stressed heart need a hand? [J].
Pu, WT ;
Izumo, S .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (10) :1765-1767
[40]   Return to the fetal gene program protects the stressed heart: a strong hypothesis [J].
Rajabi, Mitra ;
Kassiotis, Christos ;
Razeghi, Peter ;
Taegtmeyer, Heinrich .
HEART FAILURE REVIEWS, 2007, 12 (3-4) :331-343